ArticleCancers2022

The In Vitro Adaptation of Patient-Derived Organoids Suggests Alternative Strategies against CMS1 Colorectal Cancer: When the Microenvironment Does Make the Difference.

Alessandro Poggi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.